# Bark, Inc.: financial statements, quarterly BARK · NYSE · CIK 1819574 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/bark.md) · [Financials](/companies/bark/financials.md) · [Filings](/companies/bark/filings.md) · [Insiders](/companies/bark/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bark/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [123](/filings/0001819574-24-000048.md) | [125](/filings/0001819574-25-000011.md) | [121 d](/filings/0001628280-26-042242.md) | [116](/filings/0001819574-25-000039.md) | [126](/filings/0001819574-25-000047.md) | [126](/filings/0001628280-26-005799.md) | [115 d](/filings/0001628280-26-042242.md) | [103](/filings/0001628280-26-054441.md) | [107](/filings/0001819574-25-000047.md) | [98.4](/filings/0001628280-26-005799.md) | [86.6 d](/filings/0001628280-26-042242.md) | [78.8](/filings/0001628280-26-054441.md) | | Cost of revenue | $m | [47.4](/filings/0001819574-23-000042.md) | [47.8](/filings/0001819574-24-000014.md) | [45.3 d](/filings/0001819574-24-000025.md) | [42.9](/filings/0001819574-24-000039.md) | [50.0](/filings/0001819574-25-000047.md) | [47.2](/filings/0001628280-26-005799.md) | [42.1 d](/filings/0001628280-26-042242.md) | [38.8](/filings/0001628280-26-054441.md) | [45.0](/filings/0001819574-25-000047.md) | [36.9](/filings/0001628280-26-005799.md) | [32.3 d](/filings/0001628280-26-042242.md) | [21.5](/filings/0001628280-26-054441.md) | | Gross profit | $m | [75.6](/filings/0001819574-24-000048.md) | [77.2](/filings/0001819574-25-000011.md) | [76.2 d](/filings/0001628280-26-042242.md) | [73.3](/filings/0001819574-25-000039.md) | [76.1](/filings/0001819574-25-000047.md) | [79.3](/filings/0001628280-26-005799.md) | [73.4 d](/filings/0001628280-26-042242.md) | [64.1](/filings/0001628280-26-054441.md) | [62.0](/filings/0001819574-25-000047.md) | [61.6](/filings/0001628280-26-005799.md) | [54.3 d](/filings/0001628280-26-042242.md) | [57.3](/filings/0001628280-26-054441.md) | | Operating income | $m | [(11.1)](/filings/0001819574-24-000048.md) | [(14.0)](/filings/0001819574-25-000011.md) | [(6.5) d](/filings/0001628280-26-042242.md) | [(10.6)](/filings/0001819574-25-000039.md) | [(5.7)](/filings/0001819574-25-000047.md) | [(12.2)](/filings/0001628280-26-005799.md) | [(6.6) d](/filings/0001628280-26-042242.md) | [(8.4)](/filings/0001628280-26-054441.md) | [(10.7)](/filings/0001819574-25-000047.md) | [(9.0)](/filings/0001628280-26-005799.md) | [(12.2) d](/filings/0001628280-26-042242.md) | [0.1](/filings/0001628280-26-054441.md) | | Interest expense | $m | [1.4](/filings/0001819574-23-000042.md) | [0.9](/filings/0001819574-24-000014.md) | [0.7 d](/filings/0001819574-24-000025.md) | [0.7](/filings/0001819574-25-000039.md) | [0.7](/filings/0001819574-25-000047.md) | [0.7](/filings/0001628280-26-005799.md) | [0.7 d](/filings/0001628280-26-042242.md) | [0.7](/filings/0001628280-26-054441.md) | [0.7](/filings/0001819574-25-000047.md) | [0.4](/filings/0001628280-26-005799.md) | [0.0 d](/filings/0001628280-26-042242.md) | [0.0](/filings/0001628280-26-054441.md) | | Income tax | $m | [0.0](/filings/0001819574-24-000048.md) | [0.0](/filings/0001819574-25-000011.md) | [0.0 d](/filings/0001628280-26-042242.md) | [0.0](/filings/0001819574-25-000039.md) | [0.0](/filings/0001819574-25-000047.md) | [0.0](/filings/0001628280-26-005799.md) | [0.0 d](/filings/0001628280-26-042242.md) | [0.0](/filings/0001628280-26-054441.md) | [0.0](/filings/0001819574-25-000047.md) | [0.0](/filings/0001628280-26-005799.md) | [0.0 d](/filings/0001628280-26-042242.md) | [0.0](/filings/0001628280-26-054441.md) | | Net income | $m | [(10.3)](/filings/0001819574-24-000048.md) | [(10.1)](/filings/0001819574-25-000011.md) | [(4.9) d](/filings/0001628280-26-042242.md) | [(10.0)](/filings/0001819574-25-000039.md) | [(5.3)](/filings/0001819574-25-000047.md) | [(11.5)](/filings/0001628280-26-005799.md) | [(6.1) d](/filings/0001628280-26-042242.md) | [(7.0)](/filings/0001628280-26-054441.md) | [(10.7)](/filings/0001819574-25-000047.md) | [(8.6)](/filings/0001628280-26-005799.md) | [(12.7) d](/filings/0001628280-26-042242.md) | [0.7](/filings/0001628280-26-054441.md) | | Diluted EPS | $ per share | [(0.06)](/filings/0001819574-24-000048.md) | [(0.06)](/filings/0001819574-25-000011.md) | not reported | [(0.06)](/filings/0001819574-25-000039.md) | [(0.03)](/filings/0001819574-25-000047.md) | [(0.07)](/filings/0001628280-26-005799.md) | not reported | [(0.83)](/filings/0001628280-26-054441.md) | [(0.06)](/filings/0001819574-25-000047.md) | [(0.05)](/filings/0001628280-26-005799.md) | not reported | [0.08](/filings/0001628280-26-054441.md) | | Basic EPS | $ per share | [(0.06)](/filings/0001819574-24-000048.md) | [(0.06)](/filings/0001819574-25-000011.md) | not reported | [(0.06)](/filings/0001819574-25-000039.md) | [(0.03)](/filings/0001819574-25-000047.md) | [(0.07)](/filings/0001628280-26-005799.md) | not reported | [(0.83)](/filings/0001628280-26-054441.md) | [(0.06)](/filings/0001819574-25-000047.md) | [(0.05)](/filings/0001628280-26-005799.md) | not reported | [0.08](/filings/0001628280-26-054441.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [161](/filings/0001819574-24-000048.md) | [131](/filings/0001819574-25-000011.md) | [125](/filings/0001628280-26-042242.md) | [118](/filings/0001819574-25-000039.md) | [115](/filings/0001819574-25-000047.md) | [115](/filings/0001628280-26-005799.md) | [94.0](/filings/0001628280-26-042242.md) | [84.7](/filings/0001628280-26-054441.md) | [63.4](/filings/0001819574-25-000047.md) | [21.7](/filings/0001628280-26-005799.md) | [19.3](/filings/0001628280-26-054441.md) | [16.1](/filings/0001628280-26-054441.md) | | Current assets | $m | [287](/filings/0001819574-23-000042.md) | [241](/filings/0001819574-24-000014.md) | [222](/filings/0001819574-25-000024.md) | [212](/filings/0001819574-24-000039.md) | [232](/filings/0001819574-24-000048.md) | [229](/filings/0001819574-25-000011.md) | [202](/filings/0001628280-26-042242.md) | [202](/filings/0001819574-25-000039.md) | [194](/filings/0001819574-25-000047.md) | [138](/filings/0001628280-26-005799.md) | [122](/filings/0001628280-26-054441.md) | [123](/filings/0001628280-26-054441.md) | | Total assets | $m | [369](/filings/0001819574-23-000042.md) | [321](/filings/0001819574-24-000014.md) | [299](/filings/0001819574-25-000024.md) | [288](/filings/0001819574-24-000039.md) | [302](/filings/0001819574-24-000048.md) | [292](/filings/0001819574-25-000011.md) | [261](/filings/0001628280-26-042242.md) | [260](/filings/0001819574-25-000039.md) | [248](/filings/0001819574-25-000047.md) | [189](/filings/0001628280-26-005799.md) | [170](/filings/0001628280-26-054441.md) | [169](/filings/0001628280-26-054441.md) | | Current liabilities | $m | [86.0](/filings/0001819574-23-000042.md) | [91.0](/filings/0001819574-24-000014.md) | [75.5](/filings/0001819574-25-000024.md) | [76.7](/filings/0001819574-24-000039.md) | [95.9](/filings/0001819574-24-000048.md) | [141](/filings/0001819574-25-000011.md) | [124](/filings/0001628280-26-042242.md) | [130](/filings/0001819574-25-000039.md) | [127](/filings/0001819574-25-000047.md) | [74.4](/filings/0001628280-26-005799.md) | [65.4](/filings/0001628280-26-054441.md) | [60.9](/filings/0001628280-26-054441.md) | | Total liabilities | $m | [218](/filings/0001819574-23-000042.md) | [176](/filings/0001819574-24-000014.md) | [159](/filings/0001819574-25-000024.md) | [160](/filings/0001819574-24-000039.md) | [178](/filings/0001819574-24-000048.md) | [179](/filings/0001819574-25-000011.md) | [161](/filings/0001628280-26-042242.md) | [166](/filings/0001819574-25-000039.md) | [162](/filings/0001819574-25-000047.md) | [107](/filings/0001628280-26-005799.md) | [98.0](/filings/0001628280-26-054441.md) | [92.4](/filings/0001628280-26-054441.md) | | Long-term debt | $m | [81.6](/filings/0001819574-23-000042.md) | [39.8](/filings/0001819574-24-000014.md) | [39.9](/filings/0001819574-25-000024.md) | [40.0](/filings/0001819574-24-000039.md) | [40.1](/filings/0001819574-24-000048.md) | [0.0](/filings/0001819574-25-000011.md) | [0.0](/filings/0001628280-26-042242.md) | not reported | not reported | [0.0](/filings/0001628280-26-005799.md) | [0.0](/filings/0001628280-26-042242.md) | not reported | | Current portion of debt | $m | not reported | not reported | [0.0](/filings/0001819574-25-000024.md) | not reported | not reported | not reported | [42.6](/filings/0001628280-26-042242.md) | [42.7](/filings/0001819574-25-000039.md) | [42.8](/filings/0001819574-25-000047.md) | [0.0](/filings/0001628280-26-005799.md) | [0.0](/filings/0001628280-26-042242.md) | not reported | | Shareholders' equity | $m | [151](/filings/0001819574-25-000011.md) | [144](/filings/0001819574-25-000011.md) | [139](/filings/0001628280-26-042242.md) | [128](/filings/0001819574-25-000047.md) | [124](/filings/0001628280-26-005799.md) | [113](/filings/0001628280-26-005799.md) | [99.5](/filings/0001628280-26-054441.md) | [94.0](/filings/0001628280-26-054441.md) | [86.5](/filings/0001628280-26-005799.md) | [81.2](/filings/0001628280-26-005799.md) | [72.0](/filings/0001628280-26-054441.md) | [76.2](/filings/0001628280-26-054441.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [2.8 d](/filings/0001819574-24-000048.md) | [15.0 d](/filings/0001819574-25-000011.md) | [(1.0) d](/filings/0001628280-26-042242.md) | [1.8](/filings/0001819574-25-000039.md) | [2.8 d](/filings/0001819574-25-000047.md) | [(1.4) d](/filings/0001628280-26-005799.md) | [(10.3) d](/filings/0001628280-26-042242.md) | [(5.4)](/filings/0001628280-26-054441.md) | [(18.1) d](/filings/0001819574-25-000047.md) | [1.7 d](/filings/0001628280-26-005799.md) | [(1.4) d](/filings/0001628280-26-042242.md) | [(3.5)](/filings/0001628280-26-054441.md) | | Capital expenditure | $m | [2.0 d](/filings/0001819574-24-000048.md) | [1.8 d](/filings/0001819574-25-000011.md) | [2.1 d](/filings/0001628280-26-042242.md) | [2.0](/filings/0001819574-25-000039.md) | [1.8 d](/filings/0001819574-25-000047.md) | [0.6 d](/filings/0001628280-26-005799.md) | [1.7 d](/filings/0001628280-26-042242.md) | [0.7](/filings/0001628280-26-054441.md) | [1.9 d](/filings/0001819574-25-000047.md) | [0.1 d](/filings/0001628280-26-005799.md) | [0.7 d](/filings/0001628280-26-042242.md) | [0.1](/filings/0001628280-26-054441.md) | | Share repurchases | $m | [4.1 d](/filings/0001819574-24-000048.md) | [0.0 d](/filings/0001819574-25-000011.md) | [2.1 d](/filings/0001628280-26-042242.md) | [4.3](/filings/0001819574-25-000039.md) | [0.9 d](/filings/0001819574-25-000047.md) | [2.8 d](/filings/0001628280-26-005799.md) | [10.5 d](/filings/0001628280-26-042242.md) | [1.8](/filings/0001628280-26-054441.md) | [0.0 d](/filings/0001819574-25-000047.md) | [0.0 d](/filings/0001628280-26-005799.md) | [0.0 d](/filings/0001628280-26-042242.md) | [0.2](/filings/0001628280-26-054441.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [176](/filings/0001819574-23-000042.md) | [178](/filings/0001819574-24-000014.md) | [178](/filings/0001819574-24-000039.md) | [177](/filings/0001819574-24-000048.md) | [176](/filings/0001819574-25-000011.md) | [176](/filings/0001819574-25-000039.md) | [175](/filings/0001819574-25-000047.md) | [176](/filings/0001628280-26-005799.md) | [8.5](/filings/0001628280-26-054441.md) | [171](/filings/0001819574-25-000047.md) | [172](/filings/0001628280-26-005799.md) | [8.8](/filings/0001628280-26-054441.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 9,033,457 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054441.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.